Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,873 | -21,443 | -9,016 | -27,115 | -18,620 |
| Depreciation Amortization | -351 | -259 | -200 | 38 | 263 |
| Other Working Capital | -1,342 | -345 | 1,373 | 5,298 | 3,423 |
| Other Operating Activity | 4,632 | 2,720 | 1,084 | 2,320 | 1,484 |
| Operating Cash Flow | $-32,934 | $-19,327 | $-6,759 | $-19,459 | $-13,450 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 54,954 | 34,506 | 25,007 | -118,399 | N/A |
| PPE Investments | -464 | -464 | -408 | -1,059 | -777 |
| Investing Cash Flow | $54,490 | $34,042 | $24,599 | $-119,458 | $-777 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 109 | 87 | 20 | 106,923 | 106,923 |
| Common Stock Repurchased | -59 | -59 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 63,275 | 63,266 |
| Financing Cash Flow | $50 | $28 | $20 | $170,198 | $170,189 |
| Beginning Cash Position | 45,473 | 45,473 | 45,473 | 14,192 | 14,192 |
| End Cash Position | 67,079 | 60,216 | 63,333 | 45,473 | 170,154 |
| Net Cash Flow | $21,606 | $14,743 | $17,860 | $31,281 | $155,962 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,934 | -19,327 | -6,759 | -19,459 | -13,450 |
| Capital Expenditure | -464 | -464 | -408 | -1,059 | -777 |
| Free Cash Flow | -33,398 | -19,791 | -7,167 | -20,518 | -14,227 |